Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 3, 2012, Pages 462-473

  Bertone Johnson, Elizabeth R ^a   McTiernan, Anne ^b,c   Thomson, Cynthia A ^d   Wactawski Wende, Jean ^e   Aragaki, Aaron K ^b   Rohan, Thomas E ^g   Vitolins, Mara Z ^f,g   Tamimi, Rulla M ^h   Johnson, Karen C ⁱ   Lane, Dorothy ^j   Rexrode, Kathryn M ^h   Peck, Jennifer D ^k   Chlebowski, Rowan T ^l   Sarto, Gloria ^m   Manson, JoAnn E ^h  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^j STONY BROOK UNIVERSITY   (United States)

^k UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^l UCLA MEDICAL CENTER   (United States)

^m UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLECALCIFEROL; ESTROGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; AGED; ARTICLE; CALCIUM INTAKE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HORMONAL THERAPY; HUMAN; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; WOMEN'S HEALTH;

AGED; BREAST; BREAST NEOPLASMS; CALCIUM, DIETARY; CASE-CONTROL STUDIES; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROGNOSIS; WOMEN'S HEALTH;

EID: 84859409068     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-1009     Document Type: Article

References (44)

1. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: Serum vitamin D and breast cancer risk. Eur J Cancer 2010;46:2196-205.
2. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 2010;121:469-77.
3. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1991-7. (Pubitemid 41161213)
4. Engel P, Fagherazzi G, Boutten A, Dupre T, Mesrine S, Boutron-Ruault MC, et al. Serum 25(OH) vitamin D and risk of breast cancer: A nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 2010;19:2341-50.
5. Hjartaker A, Thoresen M, Engeset D, Lund E. Dairy consumption and calcium intake and risk of breast cancer in a prospective cohort: The Norwegian Women and Cancer Study. Cancer Causes Control 2010; 21:1875-85.
6. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008;100:1581-91.
7. McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, Horst RL, et al. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: A nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res 2009;11:R64.
8. Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, McCarty CA, et al. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2008;17:889-94. (Pubitemid 351536420)
9. Bertone-Johnson ER. Prospective studies of dietary vitamin D and breast cancer: More questions raised than answered. Nutr Rev 2007;65:459-66. (Pubitemid 351804346)
10. Bertone-Johnson ER. Vitamin D and breast cancer. Ann Epidemiol 2009;19:462-7.
11. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-69.
12. Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density: A hormonally responsive risk factor for breast cancer. J Br Menopause Soc 2006;12:186-93. (Pubitemid 46017608)
13. Welsh J. Vitamin D metabolism in mammary gland and breast cancer. Mol Cell Endocrinol 2011;347:55-60.
14. Cui Y, Rohan TE. Vitamin D, calcium, and breast cancer risk: A review. Cancer Epidemiol Biomarkers Prev 2006;15:1427-37. (Pubitemid 44299311)
15. Bertone-Johnson ER, Chlebowski RT, Manson JE, Wactawski-Wende J, Aragaki AK, Tamimi RM, et al. Dietary vitamin D and calcium intake and mammographic density in postmenopausal women. Menopause 2010;17:1152-60.
16. Green AK, Hankinson SE, Bertone-Johnson ER, Tamimi RM. Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women. Int J Cancer 2010;127:667-74.
17. Berube S, Diorio C, Verhoek-Oftedahl W, Brisson J. Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2004;13:1466-72. (Pubitemid 39202313)
18. Brisson J, Berube S, Diorio C, Sinotte M, Pollak M, Masse B. Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin D. Cancer Epidemiol Biomarkers Prev 2007;16:929-33. (Pubitemid 46910094)
19. Tseng M, Byrne C, Evers KA, Daly MB. Dietary intake and breast density in high-risk women: A cross-sectional study. Breast Cancer Res 2007;9:R72.
20. Thomson CA, Arendell LA, Bruhn RL, Maskarinec G, Lopez AM, Wright NC, et al. Pilot study of dietary influences on mammographic density in pre- and postmenopausal hispanic and non-hispanic white women. Menopause 2007;14:243-50. (Pubitemid 46673476)
21. Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA. Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 2000;9: 151-60. (Pubitemid 30111937)
22. Knight JA, Vachon CM, Vierkant RA, Vieth R, Cerhan JR, Sellers TA. No association between 25-hydroxyvitamin D and mammographic density. Cancer Epidemiol Biomarkers Prev 2006;15:1988-92. (Pubitemid 44664279)
23. Berube S, Diorio C, Masse B, Hebert-Croteau N, Byrne C, Cote G, et al. Vitamin D and calcium intakes from food or supplements and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005;14:1653-9. (Pubitemid 40995075)
24. Diorio C, Berube S, Byrne C, Masse B, Hebert-Croteau N, Yaffe M, et al. Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density. Cancer Res 2006;66:588-97. (Pubitemid 43166068)
25. Diorio C, Sinotte M, Brisson J, Berube S, Pollak M. Vitamin D pathway polymorphisms in relation to mammographic breast density. Cancer Epidemiol Biomarkers Prev 2008;17:2505-8.
26. Colangelo LA, Chiu BCH, Lopez P, Scholtens D, Willis LC, Edward Hendrick R, et al.Apilot study of vitamin D, calcium, and percent breast density in hispanic women. Nutr Research 2006;26:11-5.
27. Chai W, Maskarinec G, Cooney RV. Serum 25-hydroxyvitamin D levels and mammographic density among premenopausal women in a multiethnic population. Eur J Clin Nutr 2010;64:652-4.
28. Sprague BL, Trentham-Dietz A, Gangnon RE, Buist DS, Burnside ES, Aiello Bowles EJ, et al. The vitamin D pathway and mammographic breast density among postmenopausal women. Breast Cancer Res Treat 2012;131:255-65.
29. Masala G, Ambrogetti D, Assedi M, Giorgi D, Del Turco MR, Palli D. Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population. Int J Cancer 2006;118:1782-9. (Pubitemid 43376444)
30. Mishra G, McCormack V, Kuh D, Hardy R, Stephen A, dos Santos Silva I. Dietary calcium and vitamin D intakes in childhood and throughout adulthood and mammographic density in a British birth cohort. Br J Cancer 2008;99:1539-43.
31. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002;288: 321-33. (Pubitemid 34761611)
32. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative Randomized Controlled Trial. JAMA 2004;291:1701-12. (Pubitemid 38489892)
33. The Women's Health Initiative Study Group. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials 1998;19:61-109.
34. Jackson RD, LaCroix AZ, Cauley JA, McGowan J. The Women's Health Initiative Calcium-vitamin D Trial: Overview and baseline characteristics of participants. Ann Epidemiol 2003;13 (9 Suppl):S98-106.
35. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al. Calciumplus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-83. (Pubitemid 43247138)
36. McTiernan A, Chlebowski RT, Martin C, Peck JD, Aragaki A, Pisano ED, et al. Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the Women's Health Initiative Randomized Trial. J Clin Oncol 2009;27: 6135-43.
37. McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative Randomized Trial. J Natl Cancer Inst 2005;97:1366-76. (Pubitemid 41487804)
38. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-5.
39. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs- Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 1999;9: 178-87. (Pubitemid 29144458)
40. Millen AE, Pettinger M, Freudenheim JL, Langer RD, Rosenberg CA, Mossavar-Rahmani Y, et al. Incident invasive breast cancer, geographic location of residence, and reported average time spent outside. Cancer Epidemiol Biomarkers Prev 2009;18:495-507.
41. Ding EL, Mehta S, Fawzi WW, Giovannucci EL. Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: Reanalysis of Women's Health Initiative Randomized Trial. Int J Cancer 2008;122:1690-4. (Pubitemid 351413414)
42. Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, Lipkin M, et al. Vitamin D and prevention of breast cancer: Pooled analysis. J Steroid Biochem Mol Biol 2007;103:708-11. (Pubitemid 46420519)
43. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007;85:649-50. (Pubitemid 46393494)
44. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press. 2010.